Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

nAChR alpha7 full agonist with procognitive and neuroprotective properties

Nov. 8, 2007

V1b receptor antagonist Org-52186 reduces stress-induced HPA axis hyperactivity

Nov. 8, 2007

Preclinical profile of a novel triple reuptake inhibitor from Roche

Nov. 8, 2007

Vectura reports positive data from second phase II clinical study of VR-040

Nov. 8, 2007

Insmed initiates phase II clinical trial of Iplex for myotonic muscular dystrophy

Nov. 8, 2007

Preclinical evaluation of Abbott calpain inhibitor points to potential in neurodegenerative disorder

Nov. 7, 2007

Vernalis presents new FAAH inhibitor with in vivo antinociceptive activity at the SfN meeting

Nov. 7, 2007

Nicastrin-targeting antibody for cancer and Alzheimer's disease

Nov. 7, 2007

Levetiracetam may prevent seizures in Alzheimer's disease patients

Nov. 7, 2007

Positive phase IIa results reported for MEM-3454 in Alzheimer's disease

Nov. 7, 2007

Popular Stories

Today's news in brief
BioWorld
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...